Clinical Trial Update: Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing Crestor (rosuvastatin) 40 mg versus atorvastatin (Lipitor) 80 mg over 26 weeks in patients with hypercholesterolemia and coronary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Lipitor (atorvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia, Coronary Heart Disease | Phase 3 | Status: COMPLETED